Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS
Open accessThe DOI matches its Crossref record; 68 of the 70 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
The field of non-pharmacological therapies for treatment resistant depression (TRD) is rapidly evolving and new somatic therapies are valuable options for patients who have failed numerous other treatments. A major challenge for clinicians (and patients alike) is how to integrate the results from published clinical trials in the clinical decision-making process.We reviewed the literature for articles reporting results for clinical trials in particular efficacy data, contraindications and side effects of somatic therapies including electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), vagal nerve stimulation (VNS) and deep brain stimulation (DBS). Each of these devices has an indication for patients with different level of treatment resistance, based on acuteness of illness, likelihood of response, costs and associated risks. ECT is widely available and its effects are relatively rapid in severe TRD, but its cognitive adverse effects may be cumbersome. TMS is safe and well tolerated, and it has been approved by FDA for adults who have failed to respond to one antidepressant, but its use in TRD is still controversial as it is not supported by rigorous double-blind randomized clinical trials. The options requiring surgical approach are VNS and DBS. VNS has been FDA-approved for TRD, however it is not indicated for management of acute illness. DBS for TRD is still an experimental area of investigation and double-blind clinical trials are underway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatments with enhanced spatial specificity such as deep brain stimulation (DBS) or transcranial magnetic stimulation (TMS), aimed to restore region-specific hypoactivity, show great promise in alleviating treatment-resistant depression in even the most severe cases (2–10).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 1×
“1% lifetime incidence, and is associated with a high rate of morbidity and mortality [1].”
BackgroundNON-INVASIVE MAGNETIC STIMULATION OF HUMAN MOTOR CORTEX
Barker, A. T., Jalinous, R., & Freeston, I. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92413-4 · Cited by 4,460 · cited 1×
“Transcranial magnetic stimulation (TMS) was introduced in 1985 as a technique to stimulate the cerebral cortex non-invasively [6].”
MethodMayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416 · cited 1×
“Subcingulate –Broadmann area 25 (SCG 25) Mayberg and colleagues have demonstrated the integral role of the subgenual cingulate cortex in both normal and pathological shifts in mood [50].”
BackgroundO’Reardon, J. P., Solvason, H. B., Janicak, P. G., Sampson, S., Isenberg, K. E., Nahas, Z., McDonald, W. M., Avery, D., Fitzgerald, P. B., Loo, C., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.018 · Cited by 1,910 · cited 1×
“Subjects were randomly assigned to either active (n = 155) or sham TMS (n = 146) conditions [21].”
Method(2003) · The Lancet · doi:10.1016/s0140-6736(03)12705-5 · Cited by 1,706 · cited 1×
“efficacy of ECT in TRD is well established, with 60% to 90% rate of acute response in TRD [3], and it is indicated specifically in severe psychotic depression, catatonia and delirious mania.”
Background(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 2×
“” Since then, one large NIMH-sponsored, multicenter, randomized, sham-controlled study has been conducted [26], and this trial showed a statistically significant difference between the treatments, but overall low rates for both response and remission.”
BackgroundMethodDeep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027 · cited 1×
“NAC In 2008, Schlaepfer and colleagues described bilateral implantation in the shell and core of the NAC in 3 patients with TRD [64].”
BackgroundSubcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression
Lozano, A. M., Mayberg, H. S., Giacobbe, P., Hamani, C., Craddock, R. C., & Kennedy, S. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.034 · Cited by 1,024 · cited 1×
“SCG25 The early open-label study recruited 20 patients [59] with an MDE and a level of treatment-resistance of 4 or 5.”
BackgroundDeep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression
Malone, D. A., Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Friehs, G. M., Eskandar, E. N., Rauch, S. L., Rasmussen, S. A., Machado, A. G., Kubu, C. S., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.029 · Cited by 897
Self-citationGreenberg, B. D., Gabriels, L. A., Malone, D. A., Rezai, A. R., Friehs, G. M., Okun, M. S., Shapira, N. A., Foote, K. D., Cosyns, P. R., Kubu, C. S., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.55 · Cited by 867 · cited 1×
“Based on previous experience with OCD patients[62], an open-label,”
Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.013 · Cited by 865 · cited 1×
“In 2010, the same group published the results for open-label 1-year study including 10 patients [65].”
BackgroundNuttin, B., Cosyns, P., Demeulemeester, H., Gybels, J., & Meyerson, B. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02376-4 · Cited by 854 · cited 3×
“Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B: Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder.”
MethodSemkovska, M., & McLoughlin, D. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.009 · Cited by 718 · cited 1×
“The most common adverse effect of ECT is acute cognitive impairment lasting from few minutes to few days [4] or some form of amnesia, either anterograde or retrograde.”
BackgroundRush, A. J., George, M. S., Sackeim, H. A., Marangell, L. B., Husain, M. M., Giller, C., Nahas, Z., Haines, S., Simpson, R. K., & Goodman, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00304-2 · Cited by 688 · cited 1×
“The results at 10 weeks were a response rate of 40% and a remission rate of 17% [40].”
Is there a future for therapeutic use of transcranial magnetic stimulation?
Ridding, M. C., & Rothwell, J. C. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2169 · Cited by 687 · cited 1×
“This analysis showed a statistically significant difference; however, other papers critically analyzed the methods applied in the clinical trials [23-25] and suggested that though the results showed strong statistical evidence of efficacy, the clinical results were not sufficient to recommend the implementation of TMS…”
ResultSartorius, A., Kiening, K. L., Kirsch, P., von Gall, C. C., Haberkorn, U., Unterberg, A. W., Henn, F. A., & Meyer-Lindenberg, A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.027 · Cited by 611 · cited 12×
“The largest controlled study was sponsored by a TMS equipment manufacturer and involved a double-blind, multisite trial with 301 medication-free patients with MDD who had not benefited from prior treatments.”
BackgroundInfluentialSlotema, C. W., Blom, J. D., Hoek, H. W., & Sommer, I. E. C. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04872gre · Cited by 584 · cited 1×
“The most recent meta-analysis [22] included 34 clinical”
MethodThe cognitive effects of electroconvulsive therapy in community settings
Sackeim, H. A., Prudic, J., Fuller, R., Keilp, J., Lavori, P. W., & Olfson, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301180 · Cited by 577 · cited 1×
“More persistent deficits seem to be associated with older age, sine wave stimulation and bitemporal electrode placement [5].”
BackgroundSackeim, H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00271-8 · Cited by 568
Klein, E., Kreinin, I., Chistyakov, A., Koren, D., Mecz, L., Marmur, S., Ben-Shachar, D., & Feinsod, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.4.315 · Cited by 542 · cited 1×
“The majority of TMS trials targeted the L DLPC with highfrequency stimulation, while only a few targeted the R DLPC with either low-frequency stimulation [9-11] or both [12-16].”
BackgroundDeep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years
Kennedy, S. H., Giacobbe, P., Rizvi, S. J., Placenza, F. M., Nishikawa, Y., Mayberg, H. S., & Lozano, A. M. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10081187 · Cited by 481 · cited 1×
“For this cohort, the follow-up has reached a mean duration of 42 months [60].”
Fitzgerald, P. B., Brown, T. L., Marston, N. A. U., Daskalakis, Z. J., de Castella, A., & Kulkarni, J. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.1002 · Cited by 458 · cited 1×
“The majority of TMS trials targeted the L DLPC with highfrequency stimulation, while only a few targeted the R DLPC with either low-frequency stimulation [9-11] or both [12-16].”
BackgroundVidebech, P. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101001011.x · Cited by 419
Rush, A. J., Sackeim, H. A., Marangell, L. B., George, M. S., Brannan, S. K., Davis, S. M., Lavori, P., Howland, R., Kling, M. A., Rittberg, B., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.024 · Cited by 400 · cited 1×
“However, follow-up observations of this cohort suggested a cumulative beneficial effect of treatment over time, reaching response rates between 27% and 34% and remission of 15% at one year [45], with similar outcomes for patients with MDD and BP depression [46].”
ResultTwo-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes
Nahas, Z., Marangell, L. B., Husain, M. M., Rush, A. J., Sackeim, H. A., Lisanby, S. H., Martinez, J. M., & George, M. S. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0902 · Cited by 390 · cited 1×
“sponse and remission rates [43,44].”
Deep Brain Stimulation for Treatment-Resistant Depression: Follow-Up After 3 to 6Years
Ballenger, J. C. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2011.08.041 · Cited by 363
Grunhaus, L., Dannon, P. N., Schreiber, S., Dolberg, O. H., Amiaz, R., Ziv, R., & Lefkifker, E. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00254-1 · Cited by 306 · cited 1×
“There have been six prospective studies to date comparing TMS and ECT in patients with a major depressive episode (MDD or bipolar depression) [32-37].”
BackgroundNeurosurgery for intractable obsessive-compulsive disorder and depression: critical issues
Greenberg, B. D., Price, L. H., Rauch, S. L., Friehs, G., Noren, G., Malone, D., Carpenter, L. L., Rezai, A. R., & Rasmussen, S. A. (2003) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(03)00005-6 · Cited by 300 · cited 5×
“The VC/VS target for DBS was developed following studies of gamma-knife capsulotomy for obsessive-compulsive disorder (OCD) and investigated in early studies by Nuttin [51] and Greenberg [52].”
MethodInfluentialLoo, C. K., & Mitchell, P. B. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.08.001 · Cited by 292 · cited 1×
“This analysis showed a statistically significant difference; however, other papers critically analyzed the methods applied in the clinical trials [23-25] and suggested that though the results showed strong statistical evidence of efficacy, the clinical results were not sufficient to recommend the implementation of TMS…”
ResultIsease, S. D., & Roup, S. T. G. (2001) · Cited by 292
Jiménez, F., Velasco, F., Salin-Pascual, R., Hernández, J. A., Velasco, M., Criales, J. L., & Nicolini, H. (2005) · Neurosurgery · doi:10.1227/01.neu.0000170434.44335.19 · Cited by 291 · cited 1×
“At present there is only one case report of successful DBS electrode implantation in the ITP for refractory depression [56].”
BackgroundRauch, S. L., Dougherty, D. D., Malone, D., Rezai, A., Friehs, G., Fischman, A. J., Alpert, N. M., Haber, S. N., Stypulkowski, P. H., Rise, M. T., et al. (2006) · Journal of Neurosurgery · doi:10.3171/jns.2006.104.4.558 · Cited by 260
Self-citationLoo, C., Mitchell, P., Sachdev, P., McDarmont, B., Parker, G., & Gandevia, S. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.946 · Cited by 243
Puigdemont, D., Pérez-Egea, R., Portella, M. J., Molet, J., de Diego-Adeliño, J., Gironell, A., Radua, J., Gómez-Anson, B., Rodríguez, R., Serra, M., et al. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001088 · Cited by 233 · cited 1×
“More recently, a Spanish group published the results of another independent openlabel trial of DBS implanted at SCG25 in 8 patients with a level of TRD of 5 [61].”
BackgroundGrunhaus, L., Schreiber, S., Dolberg, O. T., Polak, D., & Dannon, P. N. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01499-3 · Cited by 230 · cited 1×
“There have been six prospective studies to date comparing TMS and ECT in patients with a major depressive episode (MDD or bipolar depression) [32-37].”
BackgroundTranscranial magnetic stimulation for depression and other psychiatric disorders
McNAMARA, B., RAY, J. L., ARTHURS, O. J., & BONIFACE, S. (2001) · Psychological Medicine · doi:10.1017/s0033291701004378 · Cited by 229 · cited 1×
“The earliest meta-analysis [17] yielded a positive result for rTMS compared to a sham control; however, it included only five controlled studies and excluded the only negative depression trial for rTMS that had been published at the time [18].”
ResultStaging methods for treatment resistant depression. A systematic review
Ruhé, H. G., van Rooijen, G., Spijker, J., Peeters, F. P. M. L., & Schene, A. H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.02.020 · Cited by 210 · cited 1×
“A recent review [2] compared five different models for classifying TRD, evolving from simply rating the adequacy of antidepressant trials to considering a more complex array of factors, including duration of illness, severity and treatment response.”
Couturier, J. L. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0514 · Cited by 207 · cited 1×
“high-frequency prefrontal DLPF rTMS compared to sham [20].”
ResultVagus nerve stimulation for depression: efficacy and safety in a European study
Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., Heuser, I., Bajbouj, M., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291707001924 · Cited by 205 · cited 1×
“open-label European study including 74 patients [42].”
Janicak, P. G., Dowd, S. M., Martis, B., Alam, D., Beedle, D., Krasuski, J., Strong, M. J., Sharma, R., Rosen, C., & Viana, M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01354-3 · Cited by 190 · cited 1×
“There have been six prospective studies to date comparing TMS and ECT in patients with a major depressive episode (MDD or bipolar depression) [32-37].”
BackgroundEranti, S., Mogg, A., Pluck, G., Landau, S., Purvis, R., Brown, R. G., Howard, R., Knapp, M., Philpot, M., Rabe-Hesketh, S., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.73 · Cited by 188
Two-year outcome of vagus nerve stimulation in treatment-resistant depression
Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181db8831 · Cited by 178 · cited 1×
“sponse and remission rates [43,44].”
Anatomy and physiology of the basal ganglia: implications for DBS in psychiatry
Kopell, B. H., & Greenberg, B. D. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.07.004 · Cited by 156 · cited 1×
“NAC then projects to the dorsomedial nucleus of the thalamus by way of the ventral tegmental area, ventral pallidum, and substantia nigra—which in turn projects back to the prefrontal cortex, orbitofrontal cortex, anterior cingulate cortex, amygdala, and hypothalamus; this forms the limbic loop of the basal ganglia [5…”
BackgroundHöppner, J., Schulz, M., Irmisch, G., Mau, R., Schläfke, D., & Richter, J. (2003) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-003-0416-7 · Cited by 144
Pridmore, S., Bruno, R., Turnier-Shea, Y., Reid, P., & Rybak, M. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001784 · Cited by 141 · cited 1×
“There have been six prospective studies to date comparing TMS and ECT in patients with a major depressive episode (MDD or bipolar depression) [32-37].”
BackgroundHadley, D., Anderson, B. S., Borckardt, J. J., Arana, A., Li, X., Nahas, Z., & George, M. S. (2011) · The Journal of ECT · doi:10.1097/yct.0b013e3181ce1a8c · Cited by 140 · cited 1×
“Three were small open-label studies [27-29], and one was double-blind, sham-controlled study of the”
BackgroundDell’Osso, B., Mundo, E., D’Urso, N., Pozzoli, S., Buoli, M., Ciabatti, M., Rosanova, M., Massimini, M., Bellina, V., Mariotti, M., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00651.x · Cited by 136 · cited 1×
“Three were small open-label studies [27-29], and one was double-blind, sham-controlled study of the”
BackgroundTranscranial magnetic stimulation for treating depression
Rodriguez-Martin, J. L., Barbanoj, J. M., Schlaepfer, T., Clos, S. S., Pérez, V, Kulisevsky, J., & Gironell, A. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003493 · Cited by 130 · cited 1×
“In 2002, Martin and colleagues published a Cochrane review of all the TMS studies available to that date [19].”
BackgroundBlumberger, D. M., Mulsant, B. H., Fitzgerald, P. B., Rajji, T. K., Ravindran, A. V., Young, L. T., Levinson, A. J., & Daskalakis, Z. J. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.579163 · Cited by 118
Stern, W. M., Tormos, J. M., Press, D. Z., Pearlman, C., & Pascual-Leone, A. (2007) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.2007.19.2.179 · Cited by 117 · cited 1×
“The majority of TMS trials targeted the L DLPC with highfrequency stimulation, while only a few targeted the R DLPC with either low-frequency stimulation [9-11] or both [12-16].”
BackgroundLong-term efficacy and safety outcomes with OROS-MPH in adults with ADHD
Buitelaar, J. K., Trott, G.-E., Hofecker, M., Waechter, S., Berwaerts, J., Dejonkheere, J., & Schäuble, B. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001131 · Cited by 112
Barrett, J., Della‐Maggiore, V., Chouinard, P. A., & Paus, T. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300411 · Cited by 111 · cited 1×
“with depression [7,8].”
Fitzgerald, P. B., Huntsman, S., Gunewardene, R., Kulkarni, J., & Daskalakis, Z. J. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007176 · Cited by 108
Bretlau, L., Lunde, M., Lindberg, L., Undén, M., Dissing, S., & Bech, P. (2008) · Pharmacopsychiatry · doi:10.1055/s-2007-993210 · Cited by 104 · cited 1×
“combination of TMS and escitalopram [30].”
Vagus Nerve Stimulation: 2-Year Outcomes for Bipolar Versus Unipolar Treatment-Resistant Depression
Nierenberg, A. A., Alpert, J. E., Gardner-Schuster, E. E., Seay, S., & Mischoulon, D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.036 · Cited by 100 · cited 1×
“However, follow-up observations of this cohort suggested a cumulative beneficial effect of treatment over time, reaching response rates between 27% and 34% and remission of 15% at one year [45], with similar outcomes for patients with MDD and BP depression [46].”
ResultJanuel, D., Dumortier, G., Verdon, C.-M., Stamatiadis, L., Saba, G., Cabaret, W., Benadhira, R., Rocamora, J.-F., Braha, S., Kalalou, K., et al. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.016 · Cited by 100 · cited 1×
“The majority of TMS trials targeted the L DLPC with highfrequency stimulation, while only a few targeted the R DLPC with either low-frequency stimulation [9-11] or both [12-16].”
BackgroundGarcía-Toro, M., Salvá, J., Daumal, J., Andres, J., Romera, M., Lafau, O., Echevarría, M., Mestre, M., Bosch, C., Collado, C. T., et al. (2005) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2004.08.005 · Cited by 99 · cited 1×
“The majority of TMS trials targeted the L DLPC with highfrequency stimulation, while only a few targeted the R DLPC with either low-frequency stimulation [9-11] or both [12-16].”
BackgroundKauffmann, C. D., Cheema, M. A., & Miller, B. E. (2004) · Depression and Anxiety · doi:10.1002/da.10144 · Cited by 94 · cited 1×
“The majority of TMS trials targeted the L DLPC with highfrequency stimulation, while only a few targeted the R DLPC with either low-frequency stimulation [9-11] or both [12-16].”
BackgroundRosa, M. A., Gattaz, W. F., Pascual-Leone, A., Fregni, F., Rosa, M. O., Rumi, D. O., Myczkowski, M., Silva, M. F., Mansur, C., Rigonatti, S. P., et al. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007127 · Cited by 88 · cited 1×
“There have been six prospective studies to date comparing TMS and ECT in patients with a major depressive episode (MDD or bipolar depression) [32-37].”
BackgroundPotential surgical targets for deep brain stimulation in treatment-resistant depression
Hauptman, J. S., DeSalles, A. A. F., Espinoza, R., Sedrak, M., & Ishida, W. (2008) · Neurosurgical Focus · doi:10.3171/foc/2008/25/7/e3 · Cited by 86 · cited 1×
“A number of research groups are currently investigating different sites for implantation of electrodes (for a complete review see [49]).”
BackgroundVelasco, F., Velasco, M., Jiménez, F., Velasco, A. L., & Salin-Pascual, R. (2005) · Neurosurgery · doi:10.1227/01.neu.0000172172.51818.51 · Cited by 75
Brunoni, A. R., & Fregni, F. (2011) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.338 · Cited by 65 · cited 1×
“This analysis showed a statistically significant difference; however, other papers critically analyzed the methods applied in the clinical trials [23-25] and suggested that though the results showed strong statistical evidence of efficacy, the clinical results were not sufficient to recommend the implementation of TMS…”
ResultRasmussen, K. G. (2011) · The Journal of ECT · doi:10.1097/yct.0b013e3181da84c6 · Cited by 54 · cited 1×
“0023) [38].”
Perspective on the economic evaluation of deep brain stimulation
McIntosh, E. (2011) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2011.00019 · Cited by 48
Eranti, S. V. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.1.73 · Cited by 45 · cited 1×
“There have been six prospective studies to date comparing TMS and ECT in patients with a major depressive episode (MDD or bipolar depression) [32-37].”
BackgroundRush, A. J., Marangell, L. B., Sackeim, H. A., George, M. S., Brannan, S. K., Davis, S. M., Howland, R., Kling, M. A., Rittberg, B. R., Burke, W. J., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.025 · Cited by 44 · cited 2×
“multicenter study of adjunctive VNS, which enrolled patients with higher level of treatment-resistance (failed to respond to two or more monotherapies and two augmentations, failure to respond to ECT), did not find a significant difference between active and sham groups at 12 weeks (15% and 10%, for response and remis…”
BackgroundStern, W. M., Tormos, J. M., Press, D. Z., et al. (2007) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19.2.179 · Cited by 21
Jhanwar, V. G., Bishnoi, R. J., & Jhanwar, M. R. (2011) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.85406 · Cited by 18
Jhanwar, V. G., Bishnoi, R. J., Singh, L., & Jhanwar, M. R. (2011) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.82543 · Cited by 8 · cited 1×
“Three were small open-label studies [27-29], and one was double-blind, sham-controlled study of the”
Background
Research works printed but not linked: 1
- Burke WJ Moreno FA Suicidality in treatment-resistant depression: results from a 24-month trial of vagus nerve stimulation Proceedings of 156th American Psychiatric Association Annual Meeting 2006 Toronto. Canada: May 20-25
Cited by
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression
Francis, T. C., & Lobo, M. K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.007 · Cited by 230
Pharmacological approaches to the challenge of treatment-resistant depression
Ionescu, D. F., Rosenbaum, J. F., & Alpert, J. E. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.2/dionescu · Cited by 212
Affective Brain–Computer Interfaces (aBCIs): A Tutorial
Wu, D., Lu, B., Hu, B., & Zeng, Z. (2023) · Proceedings of the IEEE · doi:10.1109/jproc.2023.3277471 · Cited by 151
Coenen, V. A., Schumacher, L. V., Kaller, C., Schlaepfer, T. E., Reinacher, P. C., Egger, K., Urbach, H., & Reisert, M. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.03.019 · Cited by 127
“Moreover, noninvasive therapies like electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) exert their therapeutic effects by possibly affecting very similar prefrontal regions (Cusin & Dougherty, 2012), opening the road for more personalized and focal interventions.”
Metadata
- Authors
- Cusin, C., & Dougherty, D. D.
- Affiliations
- Massachusetts General Hospital (US)
- Corresponding author
- Cusin, Cristina
- Venue
- Biology of Mood & Anxiety Disorders
- Published
- 2012-08-17
- Volume
- 2
- Issue
- 1
- Pages
- 14-14
- ISSN
- 2045-5380 (ISSN-L)
- PMC
- PMC3514332
- OpenAlex
- W2148550679
- Cited by
- 98
- References
- 69
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 9 · 2023: 14 · 2022: 15 · 2021: 3 · 2020: 3 · 2019: 9 · 2018: 10 · 2017: 4 · 2016: 5 · 2015: 8 · 2014: 8 · 2013: 4
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-01-01)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Biology of Mood & Anxiety Disorders (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- treatment-resistant depression, somatic therapy, electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, deep brain stimulation, non-pharmacological treatment, cognitive side effects, treatment selection, clinical decision-making
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.